Viewing Study NCT01106508


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-03-08 @ 12:33 AM
Study NCT ID: NCT01106508
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2010-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
None Recurrent or Refractory Medulloblastoma View
None Locally Advanced or Metastatic Basal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced solid tumors View
None recurrent or refractory medulloblastoma View
None locally advanced or metastatic basal cell carcinoma View
None hedgehog pathway inhibitor View